Global Survey Highlights Drug Development Challenges and Opportunities
PPD
NOVEMBER 4, 2024
The PPD clinical research business of Thermo Fisher Scientific has conducted a comprehensive survey involving 150 drug developers from around the world. This year’s findings reveal a nuanced landscape where rising clinical trial costs, complex protocol designs and patient recruitment issues have emerged as significant challenges.
Let's personalize your content